Filing Flows › Companies › Profound Medical › Timeline
Profound Medical stock timeline
A year of the price with every insider trade, planned sale, earnings report and material 8-K marked
252 sessions+23.2% to $7.21
Profound Medical (PROF) stock rose 23% over the last 252 sessions, to $7.21. On the way it reported 5 quarters, its insiders filed no open-market trades (10b5-1 plan sales aside), and the company filed 5 material 8-Ks. Each is marked on the price and listed with what the stock did next.
Each mark, and what followed
| Date | Kind | What | Next session | 5 sessions | 21 sessions |
|---|---|---|---|---|---|
| Nov 5, 2026 | Earnings | Earnings: missed the EPS estimate by -7.7% | −4.0% (+0.5% vs SPY) | — | — |
| Sep 3, 2026 | 8-K | Directors and officers: departures, appointments, pay | −0.3% (−1.3% vs SPY) | −13.5% (−12.5% vs SPY) | −15.5% (−16.4% vs SPY) |
| Aug 17, 2026 | 8-K | Directors and officers: departures, appointments, pay | −1.2% (−0.7% vs SPY) | +2.4% (+3.8% vs SPY) | −15.5% (−13.0% vs SPY) |
| Aug 6, 2026 | Earnings | Earnings: missed the EPS estimate by -7.2% | −0.6% (−0.5% vs SPY) | −14.2% (−14.6% vs SPY) | −16.1% (−16.6% vs SPY) |
| May 7, 2026 | Earnings | Earnings: beat the EPS estimate by 25.2% | −0.8% (−0.5% vs SPY) | −1.7% (−2.8% vs SPY) | −8.1% (−8.6% vs SPY) |
| Mar 10, 2026 | 8-K | Directors and officers: departures, appointments, pay | +3.6% (+3.8% vs SPY) | +7.8% (+8.8% vs SPY) | +17.4% (+16.8% vs SPY) |
| Mar 5, 2026 | Earnings | Earnings: beat the EPS estimate by 1.2% | +0.1% (+0.7% vs SPY) | −28.8% (−27.5% vs SPY) | −15.1% (−11.0% vs SPY) |
| Dec 31, 2025 | 8-K | Material definitive agreement | −2.7% (−2.9% vs SPY) | +7.5% (+6.4% vs SPY) | −1.4% (−3.4% vs SPY) |
| Dec 19, 2025 | 8-K | Material definitive agreement | −3.9% (−4.5% vs SPY) | −3.9% (−4.9% vs SPY) | +1.3% (+0.1% vs SPY) |
| Nov 13, 2025 | Earnings | Earnings: beat the EPS estimate by 30.9% | −1.9% (−0.2% vs SPY) | −6.4% (−3.3% vs SPY) | +12.4% (+12.7% vs SPY) |
What this kind of 8-K usually did
| Item | 8-Ks | Next session, median | Up next session | 21 sessions, median | Typical size |
|---|---|---|---|---|---|
| 1.01 Material definitive agreement | 23,525 | 0.0% | 51% | +1.0% | ±1.4% |
| 5.02 Directors and officers: departures, appointments, pay | 39,174 | −0.1% | 48% | +0.7% | ±1.4% |
Across every company in the move-odds universe, measured from the close before the filing. Every 8-K item ranked →
Report card: every quarter against the estimate → Profound Medical: every quarter → Live insider trades →
Prices are daily closes; filings and trades are as filed with the SEC (Form 4 within two business days of the trade, 8-K within four of the event). Moves after a mark are the stock's close-to-close change and the same for SPY; they describe the record, not what the next one will do. Not investment advice.